BioSpace News Archive

Pharm Country

Artemis Therapeutics Receives Orphan Drug Designation From FDA for Artemisone for the Treatment of Malaria

Artemis is now qualified to receive significant benefits throughout its orphan drug development program including more frequent FDA interactions, protocol assistance, and tax credits for clinical research costs.

November 6, 2017

·

3 min read

Drug Development

Flex Pharma Reports Positive Topline Data From Exploratory Phase II Trial of FLX-787 in ALS

The study was terminated early to focus the Company’s resources on the ongoing US Phase 2b ALS study (COMMEND).

November 6, 2017

·

7 min read

Drug Development

Tetra Discovery Partners Research Supports Ability of Novel Selective PDE4D Inhibitor, BPN14770, to Improve Memory and Cognition

BPN14770 is a highly selective inhibitor of PDE4D, which regulates brain signaling pathways involved in the early and late stages of memory formation.

November 6, 2017

·

5 min read

Drug Development

Wave Life Sciences Initiates Clinical Trial for Lead Program in Duchenne Muscular Dystrophy

This clinical trial marks the next stage in the company’s ongoing commitment to address the significant unmet needs of patients diagnosed with this devastating disease and it is the company’s third clinical trial initiated in 2017.

November 6, 2017

·

7 min read

Biotech Bay

Natera Selected for Circulating Tumor DNA Study in Colorectal Cancer

Natera today announced a second research collaboration with Denmark’s Aarhus University utilizing the company’s Signatera technology to evaluate ctDNA as a useful biomarker for detecting minimal residual disease, treatment response, and disease recurrence in colorectal cancer patients.

November 6, 2017

·

5 min read

Biotech Beach

ResMed Adds Remote Patient Monitoring to AirMini, World’s Smallest CPAP

ResMed today announced that AirMini, the world’s smallest PAP device, is now connected to AirView, the world’s largest remote patient monitoring platform.

November 6, 2017

·

2 min read

BioMidwest

Exicure Closes Additional $11.2 Million in Private Financing to Advance Its Gene Regulatory and Immunotherapeutic Programs

Exicure today announced the closing of approximately $11.2 million in subsequent financing led by Luye Pharma Group and others including Eager Info Investments LTD, Knoll Capital Management and Purple Arch Ventures.

November 6, 2017

·

4 min read

Drug Development

UroGen Pharma Announces First Patient Enrolled in Allergan Phase II Clinical Trial of RTGel in Combination With BOTOX for the Treatment of Overactive Bladder

The trial is being conducted by Allergan Pharmaceuticals International Limited, or Allergan, a wholly owned subsidiary of Allergan plc, under the terms of a license agreement with UroGen Pharma.

November 6, 2017

·

5 min read

Business

Atonarp and IMA Life Enter Supply Agreement For Pharmaceutical Lyophilization Applications

The AMS solution was developed in collaboration between IMA Life, Atonarp and a major pharma company with purpose-built quantitative instrumentation for the application of freeze-drying and aseptic processing.

November 6, 2017

·

3 min read

Business

Summit Announces Signing of Revenue Sharing Agreement With the Wellcome Trust for CDI Antibiotic Ridinilazole

Entering revenue share in accordance with terms of prior Wellcome Trust funding award agreement.

November 6, 2017

·

6 min read